Sugimoto H - Search Results

1

Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.

Zheng X, Carstens JL, Kim J, Scheible M, Kaye J, Sugimoto H, Wu CC, LeBleu VS, Kalluri R. Zheng X, et al. Among authors: sugimoto h. Nature. 2015 Nov 26;527(7579):525-530. doi: 10.1038/nature16064. Epub 2015 Nov 11. Nature. 2015. PMID: 26560028 Free PMC article.

2

Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria.

Sugimoto H, Hamano Y, Charytan D, Cosgrove D, Kieran M, Sudhakar A, Kalluri R. Sugimoto H, et al. J Biol Chem. 2003 Apr 11;278(15):12605-8. doi: 10.1074/jbc.C300012200. Epub 2003 Jan 21. J Biol Chem. 2003. PMID: 12538598 Free article.

3

Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins.

Sudhakar A, Sugimoto H, Yang C, Lively J, Zeisberg M, Kalluri R. Sudhakar A, et al. Among authors: sugimoto h. Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4766-71. doi: 10.1073/pnas.0730882100. Epub 2003 Apr 7. Proc Natl Acad Sci U S A. 2003. PMID: 12682293 Free PMC article.

4

BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.

Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R. Zeisberg M, et al. Among authors: sugimoto h. Nat Med. 2003 Jul;9(7):964-8. doi: 10.1038/nm888. Nat Med. 2003. PMID: 12808448

5

Thrombospondin-1 associated with tumor microenvironment contributes to low-dose cyclophosphamide-mediated endothelial cell apoptosis and tumor growth suppression.

Hamano Y, Sugimoto H, Soubasakos MA, Kieran M, Olsen BR, Lawler J, Sudhakar A, Kalluri R. Hamano Y, et al. Among authors: sugimoto h. Cancer Res. 2004 Mar 1;64(5):1570-4. doi: 10.1158/0008-5472.can-03-3126. Cancer Res. 2004. PMID: 14996710

6

TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function.

Reiser J, Polu KR, Möller CC, Kenlan P, Altintas MM, Wei C, Faul C, Herbert S, Villegas I, Avila-Casado C, McGee M, Sugimoto H, Brown D, Kalluri R, Mundel P, Smith PL, Clapham DE, Pollak MR. Reiser J, et al. Among authors: sugimoto h. Nat Genet. 2005 Jul;37(7):739-44. doi: 10.1038/ng1592. Epub 2005 May 27. Nat Genet. 2005. PMID: 15924139 Free PMC article.

7

Bone-marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease.

Sugimoto H, Mundel TM, Sund M, Xie L, Cosgrove D, Kalluri R. Sugimoto H, et al. Proc Natl Acad Sci U S A. 2006 May 9;103(19):7321-6. doi: 10.1073/pnas.0601436103. Epub 2006 Apr 28. Proc Natl Acad Sci U S A. 2006. PMID: 16648256 Free PMC article.

8

Identification of fibroblast heterogeneity in the tumor microenvironment.

Sugimoto H, Mundel TM, Kieran MW, Kalluri R. Sugimoto H, et al. Cancer Biol Ther. 2006 Dec;5(12):1640-6. doi: 10.4161/cbt.5.12.3354. Epub 2006 Dec 5. Cancer Biol Ther. 2006. PMID: 17106243 Free article.

9

BMP-7 functions as a novel hormone to facilitate liver regeneration.

Sugimoto H, Yang C, LeBleu VS, Soubasakos MA, Giraldo M, Zeisberg M, Kalluri R. Sugimoto H, et al. FASEB J. 2007 Jan;21(1):256-64. doi: 10.1096/fj.06-6837com. Epub 2006 Nov 20. FASEB J. 2007. PMID: 17116741

10

Renal fibrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein-7 and advanced glycation end product inhibitors.

Sugimoto H, Grahovac G, Zeisberg M, Kalluri R. Sugimoto H, et al. Diabetes. 2007 Jul;56(7):1825-33. doi: 10.2337/db06-1226. Epub 2007 Apr 24. Diabetes. 2007. PMID: 17456853

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,720 results

Search Page

Filters